|
Video: What is a Stock Split?
|
|
Vivos Therapeutics is a medical technology company focused on the development and commercialization of a suite of diagnostic and treatment modalities for patients with cranial and/or dentofacial abnormalities and the array of medical conditions that may result from them, including mild to moderate obstructive sleep apnea and snoring in adults. Co. calls its solution The Vivos Method. The Vivos Method is a therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by Co. and prescribed by trained dentists in cooperation with their medical colleagues. According to our Vivos Therapeutics stock split history records, Vivos Therapeutics has had 1 split. | |
|
Vivos Therapeutics (VVOS) has 1 split in our Vivos Therapeutics stock split history database. The split for VVOS took place on October 27, 2023. This was a 1 for 25 reverse split, meaning for each 25 shares of VVOS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as Vivos Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Vivos Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vivos Therapeutics shares, starting with a $10,000 purchase of VVOS, presented on a split-history-adjusted basis factoring in the complete Vivos Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/14/2020 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$194.75 |
|
End price/share: |
$2.46 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.74% |
|
Average Annual Total Return: |
-72.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$126.29 |
|
Years: |
3.36 |
|
|
|
Date |
Ratio |
10/27/2023 | 1 for 25 |
|
|